- Home
- BOH vs VCYT Comparison
BOH vs VCYT Comparison
Compare BOH & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOH
- VCYT
- Stock Information
- Founded
- BOH 1897
- VCYT 2006
- Country
- BOH United States
- VCYT United States
- Employees
- BOH N/A
- VCYT N/A
- Industry
- BOH Major Banks
- VCYT Medical Specialities
- Sector
- BOH Finance
- VCYT Health Care
- Exchange
- BOH Nasdaq
- VCYT Nasdaq
- Market Cap
- BOH 2.6B
- VCYT 2.4B
- IPO Year
- BOH N/A
- VCYT 2013
- Fundamental
- Price
- BOH $68.02
- VCYT $30.88
- Analyst Decision
- BOH Hold
- VCYT Buy
- Analyst Count
- BOH 6
- VCYT 9
- Target Price
- BOH $72.33
- VCYT $39.89
- AVG Volume (30 Days)
- BOH 350.4K
- VCYT 979.1K
- Earning Date
- BOH 10-27-2025
- VCYT 11-05-2025
- Dividend Yield
- BOH 4.12%
- VCYT N/A
- EPS Growth
- BOH 7.02
- VCYT N/A
- EPS
- BOH 3.81
- VCYT 0.34
- Revenue
- BOH $657,046,000.00
- VCYT $479,129,000.00
- Revenue This Year
- BOH $14.47
- VCYT $14.19
- Revenue Next Year
- BOH $7.03
- VCYT $9.68
- P/E Ratio
- BOH $17.85
- VCYT $91.99
- Revenue Growth
- BOH 3.70
- VCYT 19.91
- 52 Week Low
- BOH $57.45
- VCYT $22.61
- 52 Week High
- BOH $82.70
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- BOH 54.36
- VCYT 55.58
- Support Level
- BOH $67.08
- VCYT $30.67
- Resistance Level
- BOH $68.96
- VCYT $32.34
- Average True Range (ATR)
- BOH 1.19
- VCYT 1.18
- MACD
- BOH 0.02
- VCYT -0.06
- Stochastic Oscillator
- BOH 39.78
- VCYT 57.89
About BOH Bank of Hawaii Corporation
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.